NVLT vaults, MMTE mammoth trader, ISIM isn’t great

Novelos Therapeutics Inc. (OTCBB: NVLT) galloped ahead 70.45 percent in midday trading Thursday to 3.75 cents on 13.5 million shares, compared to a full-day average of 363,282. The Newton, Mass.-based biopharmaceutical company announced that today a poster highlighting positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer is being presented at a symposium in Texas.

Mammoth Energy Group Inc. (Pink Sheets: MMTE) traded in 122.8 million shares Thursday, in contrast with a daily average of 20.49 million. Prices were flat at three-100ths of a cent. The New York-based lithium and alternative energy mining company, announced today that expected demand and sales growth for lithium ion batteries is expected to triple to $60 Billion in the next 10 years.

Insight Management Corp. (OTCBB: ISIM) trailed Wednesday’s close by 33.33 percent to eight-100ths of a cent Thursday. Volume was 33.82 million shares, or double its full-day average. The New York-based green construction company has completed the acquisition of Plant Acadia Growing, Inc., the parent company of Simpson Brothers Greenhouse, LLC, a retail greenhouse and wholesale farm supplier.

Tags: alternative energy stocks, infrastructure stocks, MMTE, NVLT, otcbb, pharmaceutical stocks

This entry was posted on Thursday, December 9th, 2010 at 12:57 pm by Glenn and is filed under Energy Stocks, Industrial Stocks, pharmaceutical stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.